Last Posted: May-13-2019 8AM
Last Posted: May 09, 2019
- Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
Pilewskie Melissa et al. Breast cancer research and treatment 2019 May 175(1) 141-148 - Trends in BRCA testing and socioeconomic deprivation.
Martin Antony P et al. European journal of human genetics : EJHG 2019 May - BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
Elezaby Mai et al. Radiology 2019 Apr 181814 - Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making.
Franceschini Gianluca et al. The breast journal 2019 May 25(3) 564-565 - Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
Nomura Hidetaka et al. International journal of clinical oncology 2019 May - A reference system for BRCA mutation detection based on next-generation sequencing in the Chinese population.
Qu Shoufang et al. The Journal of molecular diagnostics : JMD 2019 Apr - Germline Missense Variants in BRCA1 : New Trends and Challenges for Clinical Annotation.
Golubeva Volha A et al. Cancers 2019 Apr 11(4) - Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
Zakrzewski Falk et al. BMC cancer 2019 Apr 19(1) 396 - Visual Abstract: Nonmetropolitan areas have lower BRCA testing rates and preventive services uptake than metropolitan areas in the United States
CDC, April 2019 - Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Lambertini M et al. Annals of oncology : official journal of the European Society for Medical Oncology 2018 29(1) 237-243
.png)
No hay comentarios:
Publicar un comentario